[1] GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736 − 88. https://doi.org/10.1016/S0140-6736(18)32203-7.
[2] Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine 2012;30(7):1244 − 54. https://doi.org/10.1016/j.vaccine.2011.12.092.
[3] Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013;382(9888):209 − 22. https://doi.org/10.1016/s0140-6736(13)60844-2.
[4] Wang LP, Zhou SX, Wang X, Lu QB, Shi LS, Ren X, et al. Etiological, epidemiological, and clinical features of acute diarrhea in China. Nat Commun 2021;12(1):2464. https://doi.org/10.1038/s41467-021-22551-z.
[5] Troeger C, Khalil IA, Rao PC, Cao SJ, Blacker BF, Ahmed T, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr 2018;172(10):958 − 65. https://doi.org/10.1001/jamapediatrics.2018.1960.
[6] Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health 2019;7(7):e893 − 903. https://doi.org/10.1016/s2214-109x(19)30207-4.
[7] Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001;344(8):564 − 72. https://doi.org/10.1056/nejm200102223440804.
[8] Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014;370(6):513 − 9. https://doi.org/10.1056/nejmoa1311738.
[9] Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, et al. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa. N Engl J Med 2018;378(16):1521 − 8. https://doi.org/10.1056/nejmoa1713909.
[10] Keating GM. Rotavirus vaccine (RotaTeq). Paediatric drugs. 2006;8(3):197-202; discussion 3-4. https://doi.org/10.2165/00148581-200608030-00008.
[11] Liu ZK, Li N, Liu GX, Xu L, Dong Y, Meng RG, et al. No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city. Emerg Microbes Infect 2023;12(2):2270062. http://dx.doi.org/10.1080/22221751.2023.2270062.
[12] Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29(16):3061 − 6. https://doi.org/10.1016/j.vaccine.2011.01.088.
[13] McIlhone KA, Best EJ, Petousis-Harris H, Howe AS. Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: a retrospective cohort study. Vaccine 2020;38(7):1730 − 9. https://doi.org/10.1016/j.vaccine.2019.12.045.
[14] Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, et al. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother 2017;13(3):703 − 10. https://doi.org/10.1080/21645515.2016.1240846.
[15] Escolano S, Hill C, Tubert-Bitter P. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. Vaccine 2015;33(8):1017 − 20. https://doi.org/10.1016/j.vaccine.2015.01.005.